Guardant Health
GH
#1755
Rank
A$17.40 B
Marketcap
A$134.02
Share price
1.04%
Change (1 day)
100.15%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: A$17.40 Billion

As of February 2026 Guardant Health has a market cap of A$17.40 Billion. This makes Guardant Health the world's 1755th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$17.40 B-12.83%
2025A$19.96 B230.23%
2024A$6.04 B25.47%
2023A$4.81 B17.7%
2022A$4.09 B-70.81%
2021A$14.02 B-16.3%
2020A$16.75 B59.88%
2019A$10.48 B129.04%
2018A$4.57 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Guardant Health was reported to be:

A$17.57 Billion
by Nasdaq info icon info icon
A$17.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
A$3.42 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$41.04 B 135.83%๐Ÿ‡บ๐Ÿ‡ธ USA